Primary Open Angle Glaucoma
3 competing products in clinical development for Primary Open Angle Glaucoma.
Pipeline by Phase
Phase 21
Phase 31
Approved1
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Brinzolamide ophthalmic suspension + Azopt® | Sun Pharmaceutical | Phase 3 | Completed | 40 |
| Latanoprost plus adjunctive glaucoma medication | Sight Sciences | Approved | Terminated | 25 |
| SBI-100 Ophthalmic Emulsion, 0.5% + SBI-100 Ophthalmic Emulsion, 1.0% + SBI-100 Ophthalmic Emulsion, Placebo | Skye Bioscience | Phase 2 | Completed | 25 |